Log-in / Create Account  
Session Information
ENDO 2011 Annual Meeting
Click here to go to the previous page
AACE vs ADA Guidelines for Diagnosis & Management of DM2
Track : CLINICAL
Program Code: CMF06
Date: Monday, June 6, 2011
Time: 8:30 AM to 8:50 AM  EST
Location: 258ABC
SPEAKER (S):
Jaime A Davidson, FACE,FACP,MD, Univ of Texas SW Med Ctr
Disclosures: JAD: Medical Advisory Board Member, Novo Nordisk; Scientific Board Member, Astra Zeneca, Bristol-Myers Squibb; Eli Lilly & Company; Merck & Co., Inc.; Speaker, Johnson & Johnson, Bayer Schering Pharma.
David M Nathan, MD, Massachusetts Gen Hosp/Harvard Med Sch
Disclosure: Nothing to Disclose

Audio Synchronized to PowerPoint
(Code: CMF6)
Attendee/Member-in-Training:
Attendee/Member:
Attendee/Non-Member:
Non-Attendee/Member-in-Training:
Non-Attendee/Member:
Members/Attendees Login
  
This session is a part of:
ENDO 2011 Annual Meeting Full Conference Online Access